iQure Pharma Attending JPM Week in San Francisco — January 9-12, 2023
Princeton, NJ, December 14, 2022 ─ iQure Pharma Inc. (iQure), a US-based global biotech company, is attending the 41st Annual J.P. Morgan...
iQure Pharma Attending JPM Week in San Francisco — January 9-12, 2023
iQure Pharma Selected to Join NYU Stern Endless Frontier Labs (EFL) 2022-2023 Life Sciences Track
iQure Pharma Secures $600K in Commitments in Early Closing to Research Neuropathic Pain Therapies
iQure Pharma Targets Future with New Board Appointments
iQure Pharma Will Present at Mid-Atlantic Diamond Venture 2022 Spring Forum
Company signed Agreement with University of Arizona for non-opioid treatment of post-operative pain
iQure Pharma Inc. Secures Private Investment of $100,000
iQure Pharma Inc. Secures Additional Investment of $50,000
Chairman Dr. Peter Schiemann, will participate at JPMorganBIO in San Francisco 12.-16. January